Standard Biotools (LAB) Cash from Investing Activities Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.39 Mn | -222.33 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.09% |
| Mar 31, 2026 | 109.97% |
| Dec 31, 2025 | -57.79% |
| Sep 30, 2025 | -20.17% |
| Jun 30, 2025 | 22.12% |
| Mar 31, 2025 | -3.48% |
| Dec 31, 2024 | 117.51% |
| Sep 30, 2024 | -46.36% |
| Jun 30, 2024 | 27.84% |
| Mar 31, 2024 | 103.15% |
| Dec 31, 2023 | -269.67% |
| Sep 30, 2023 | -129.92% |
| Jun 30, 2023 | 57.06% |
| Mar 31, 2023 | 178.01% |
| Dec 31, 2022 | 65.39% |
| Sep 30, 2022 | 88.76% |
| Jun 30, 2022 | -109.67% |
| Mar 31, 2022 | -15.43% |
| Sep 30, 2021 | -25.39% |
| Jun 30, 2021 | -101.41% |